Clinical Trial Update: Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of noscapine in patients with low-grade non-Hodgkin lymphoma or chronic lymphocytic leukemia refractory to chemotherapy was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Noscapine (noscapine)

Snippet

Sponsor: University of Southern California | Conditions: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: TERMINATED